Delivery Order SPE2DB24D1201-SPE2DB25FJDQA
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $3,768.42 to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Zepbound 7.5 mg/0.5 ml pens. This firm fixed price contract, which is not set-aside and is scheduled for completion by July 28, 2025, represents a competitive award to the pharmaceutical distributor for medical supplies supporting federal healthcare operations. The delivery will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a $25,617.61 delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Zepbound 5 mg/0.5 mL pen injections. This is a firm fixed price, competitively awarded contract with an ultimate completion date of July 23, 2025, and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to the company's headquarters in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Zepbound 15 mg/0.5 mL pens with a ceiling value of $4,278.90. This is a firm fixed price delivery order with an ultimate completion date of July 22, 2025, executed under the non-set-aside competitive procurement process. The order will be fulfilled at AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This...
- The Defense Logistics Agency awarded a $5,514.02 delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Zepbound 5 mg/0.5 mL pens. This firm fixed-price, competitively awarded contract is classified as a child order under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which carries a $999,999,999 ceiling value and extends through December 2026. The pharmaceutical product will be delivered to AmerisourceBergen's...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,048.25 for Zepbound 10 mg/0.5 mL pen injectors on July 25, 2025, with an ultimate completion date of July 28, 2025. This firm fixed-price, competitively awarded contract carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a continuation of AmerisourceBergen's extensive pharmaceutical supply...
- The Defense Logistics Agency (DLA) awarded a $13,398.50 delivery order to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 mL pens on July 25, 2025, with an ultimate completion date of July 28, 2025. This firm fixed-price delivery order, issued without a set-aside designation, represents a competitively awarded contract for pharmaceutical supply to support federal medical procurement needs. The place of performance is located at AmerisourceBergen's corporate office in...
- The Defense Logistics Agency awarded a $6,658.36 delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Zepbound 5 mg/0.5 mL pens. This firm fixed-price, competitively awarded contract will be fulfilled from the vendor's Conshohocken, Pennsylvania location, with an ultimate completion date of July 22, 2025. The award carries no set-aside designation, indicating it was openly competed among qualified pharmaceutical distributors. This delivery order is issued under...
- The Defense Logistics Agency awarded a $2,465.15 delivery order to AmerisourceBergen Drug Corp for Zepbound 5 mg/0.5 mL pens on July 22, 2025, with completion scheduled for July 23, 2025. This firm fixed price, non-set-aside contract represents a small-value pharmaceutical delivery to support federal medical procurement needs. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for military and veteran healthcare systems through its extensive...
- The Defense Logistics Agency awarded a $19,662.17 delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Zepbound 12.5 mg/0.5 ml pen injections. This is a firm fixed price, competitively awarded contract with an ultimate completion date of July 28, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Zepbound 7.5 mg/0.5 mL pens valued at $9,721.62. This is a firm fixed-price delivery order with no set-aside designation, executed under competitive procedures. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 25, 2025. This delivery order is a child contract issued under...
- SPE2DB24D1201Indefinite Delivery Contract
- SPE2DB24D1201-SPE2DB25FJDQADelivery Order
The Defense Logistics Agency awarded a $9,018.43 delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Zepbound 5 mg/0.5 mL pens. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of July 25, 2025. The product will be delivered to AmerisourceBergen's place of performance in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as a major pharmaceutical distributor serving federal medical procurement needs. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and extending through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including customers such as the Defense Health Agency and U.S. Coast Guard. The company's demonstrated capability to fulfill federal medical supply requirements through open competition, combined with its extensive portfolio of therapeutic medications and medical commodities, positions it as a critical vendor within the Defense Logistics Agency's medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.0k | 7/24/25 |